Logo image of BYON

BEYOND INC (BYON) Stock Fundamental Analysis

USA - NYSE:BYON - US6903701018 - Common Stock

9.44 USD
+0.32 (+3.51%)
Last: 8/28/2025, 8:04:00 PM
9.59 USD
+0.15 (+1.59%)
After Hours: 8/28/2025, 8:04:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BYON. BYON was compared to 119 industry peers in the Specialty Retail industry. BYON has a bad profitability rating. Also its financial health evaluation is rather negative. BYON has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BYON has reported negative net income.
In the past year BYON has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: BYON reported negative net income in multiple years.
In multiple years BYON reported negative operating cash flow during the last 5 years.
BYON Yearly Net Income VS EBIT VS OCF VS FCFBYON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

BYON has a Return On Assets of -56.28%. This is amonst the worse of the industry: BYON underperforms 94.31% of its industry peers.
Looking at the Return On Equity, with a value of -153.98%, BYON is doing worse than 75.61% of the companies in the same industry.
Industry RankSector Rank
ROA -56.28%
ROE -153.98%
ROIC N/A
ROA(3y)-39%
ROA(5y)-15.57%
ROE(3y)-83.49%
ROE(5y)-37.9%
ROIC(3y)N/A
ROIC(5y)N/A
BYON Yearly ROA, ROE, ROICBYON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

BYON's Gross Margin of 23.10% is on the low side compared to the rest of the industry. BYON is outperformed by 75.61% of its industry peers.
In the last couple of years the Gross Margin of BYON has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for BYON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y0.73%
BYON Yearly Profit, Operating, Gross MarginsBYON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

1

2. Health

2.1 Basic Checks

BYON does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BYON has more shares outstanding
BYON has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BYON is higher compared to a year ago.
BYON Yearly Shares OutstandingBYON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BYON Yearly Total Debt VS Total AssetsBYON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

BYON has an Altman-Z score of 0.21. This is a bad value and indicates that BYON is not financially healthy and even has some risk of bankruptcy.
BYON has a worse Altman-Z score (0.21) than 77.24% of its industry peers.
BYON has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.14, BYON is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 0.21
ROIC/WACCN/A
WACC9.27%
BYON Yearly LT Debt VS Equity VS FCFBYON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

BYON has a Current Ratio of 0.91. This is a bad value and indicates that BYON is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BYON (0.91) is worse than 77.24% of its industry peers.
BYON has a Quick Ratio of 0.91. This is a bad value and indicates that BYON is not financially healthy enough and could expect problems in meeting its short term obligations.
BYON's Quick ratio of 0.87 is fine compared to the rest of the industry. BYON outperforms 74.80% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.87
BYON Yearly Current Assets VS Current LiabilitesBYON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

BYON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.89%, which is quite good.
Looking at the last year, BYON shows a very negative growth in Revenue. The Revenue has decreased by -26.63% in the last year.
BYON shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.56% yearly.
EPS 1Y (TTM)16.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.34%
Revenue 1Y (TTM)-26.63%
Revenue growth 3Y-20.31%
Revenue growth 5Y-0.56%
Sales Q2Q%-29.1%

3.2 Future

The Earnings Per Share is expected to grow by 17.46% on average over the next years. This is quite good.
Based on estimates for the next years, BYON will show a quite strong growth in Revenue. The Revenue will grow by 13.73% on average per year.
EPS Next Y77.84%
EPS Next 2Y36.79%
EPS Next 3Y23.39%
EPS Next 5Y17.46%
Revenue Next Year-26.42%
Revenue Next 2Y-9.4%
Revenue Next 3Y-0.88%
Revenue Next 5Y13.73%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BYON Yearly Revenue VS EstimatesBYON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
BYON Yearly EPS VS EstimatesBYON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BYON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BYON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BYON Price Earnings VS Forward Price EarningsBYON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BYON Per share dataBYON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

BYON's earnings are expected to grow with 23.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.79%
EPS Next 3Y23.39%

More info and screens

0

5. Dividend

5.1 Amount

BYON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEYOND INC

NYSE:BYON (8/28/2025, 8:04:00 PM)

After market: 9.59 +0.15 (+1.59%)

9.44

+0.32 (+3.51%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-28 2025-07-28/amc
Earnings (Next)10-22 2025-10-22/bmo
Inst Owners59.06%
Inst Owner ChangeN/A
Ins Owners1.57%
Ins Owner Change6.48%
Market Cap541.95M
Revenue(TTM)1.13B
Net Income(TTM)-201514000
Analysts74.29
Price Target11.12 (17.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.86%
Min EPS beat(2)21.2%
Max EPS beat(2)46.52%
EPS beat(4)2
Avg EPS beat(4)-33.62%
Min EPS beat(4)-121.07%
Max EPS beat(4)46.52%
EPS beat(8)3
Avg EPS beat(8)-34.81%
EPS beat(12)6
Avg EPS beat(12)-36.04%
EPS beat(16)9
Avg EPS beat(16)-27.97%
Revenue beat(2)1
Avg Revenue beat(2)-5.28%
Min Revenue beat(2)-21.15%
Max Revenue beat(2)10.58%
Revenue beat(4)1
Avg Revenue beat(4)-8.17%
Min Revenue beat(4)-21.15%
Max Revenue beat(4)10.58%
Revenue beat(8)3
Avg Revenue beat(8)-4.11%
Revenue beat(12)5
Avg Revenue beat(12)-3.62%
Revenue beat(16)6
Avg Revenue beat(16)0.87%
PT rev (1m)0%
PT rev (3m)51.39%
EPS NQ rev (1m)17.7%
EPS NQ rev (3m)23.95%
EPS NY rev (1m)20.2%
EPS NY rev (3m)20.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-19.61%
Revenue NY rev (1m)1.82%
Revenue NY rev (3m)1.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.48
P/FCF N/A
P/OCF N/A
P/B 4.14
P/tB 5.88
EV/EBITDA N/A
EPS(TTM)-3.64
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-1.97
FCFYN/A
OCF(TTM)-1.72
OCFYN/A
SpS19.66
BVpS2.28
TBVpS1.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -56.28%
ROE -153.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.1%
FCFM N/A
ROA(3y)-39%
ROA(5y)-15.57%
ROE(3y)-83.49%
ROE(5y)-37.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y0.73%
F-Score5
Asset Turnover3.15
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 73.64%
Cap/Sales 1.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.87
Altman-Z 0.21
F-Score5
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)142.46%
Cap/Depr(5y)112.5%
Cap/Sales(3y)1.7%
Cap/Sales(5y)1.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.34%
EPS Next Y77.84%
EPS Next 2Y36.79%
EPS Next 3Y23.39%
EPS Next 5Y17.46%
Revenue 1Y (TTM)-26.63%
Revenue growth 3Y-20.31%
Revenue growth 5Y-0.56%
Sales Q2Q%-29.1%
Revenue Next Year-26.42%
Revenue Next 2Y-9.4%
Revenue Next 3Y-0.88%
Revenue Next 5Y13.73%
EBIT growth 1Y39.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year79.31%
EBIT Next 3Y27.11%
EBIT Next 5Y20.13%
FCF growth 1Y-92.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-534.55%
OCF growth 3YN/A
OCF growth 5YN/A